Cramer: Sell BankUnited and Buy Acorda, Charles River Labs and These 2 Sizzling Stocks
January 10, 2013
Jim Cramer made the following calls on January 9th, 2013. What do you think about his picks?
Acorda Therapeutics, Inc. (NASDAQ:ACOR): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy on June 19, 2012. The stock’s 52-week high is $28.46, and its 52-week low is $21.04.
Current Price $27.34
Premium Newsletters
Gold & Silver
Don't miss one of the biggest bull markets in history! Covers Gold, Silver, Gold & Silver stocks, and miners.
Learn More
Commodities Premium
There's always a bull market in some sector! Find the best opportunities in commodities.
Learn more
ETF Investing
At last, a trading system that buys the right ETFs at the right time, time after time!
Learn more
Wall St. Cheat Sheet has been featured in these fine media outlets:
